SPR® Therapeutics Recognized as a Top Workplace in Northeast Ohio for the Third Year in a Row
June 23 2024 - 10:00AM
SPR Therapeutics has been honored as a Top Workplace for the third
consecutive year by cleveland.com and The Plain Dealer Top
Workplaces program. Award winners are based solely on employee
feedback gathered through a third-party survey administered by
employee engagement technology partner Energage LLC. The
confidential survey uniquely measures the employee experience and
its component themes, including employees feeling respected and
supported, enabled to grow, and empowered to execute among other
important topics aligned with high-performing workplaces.
The Top Workplace recognition comes as SPR has made significant
strides amidst exponential growth, doubling the number of team
members in the last two years and significantly accelerating the
commercial growth and adoption of the SPRINT® PNS System to address
acute and chronic pain. Feedback garnered as part of the survey
process highlighted employee connection to the mission and strong
alignment with the SPR team.
- 96 percent indicated that the company operates driven by strong
values.
- 97 percent said their job makes them feel part of something
meaningful.
- 93 percent feel genuinely appreciated SPR Therapeutics.
Based on exceptionally strong responses from employees, SPR was
also awarded the Top Workplace ‘Meaningfulness Award’ across all
company categories, recognizing the strong connection to the
mission and impact of work done at the organization.
“These awards highlight our ability to stay true to our company
credo and values while navigating our expansion. We are proud of
our collaborative, innovative culture which has helped us drive
year-over-year growth as we continue to increase the utilization of
SPRINT PNS across the U.S.,” said Maria Bennett, President, CEO and
Founder of SPR Therapeutics. “As a company, we put the best
interests of patients at the center of everything we do, and the
success we’ve had would not be possible without every member of our
team working together to achieve our goals. I’m proud that we
continue to attract and develop talented, passionate team members
while executing our commercial expansion and maintaining our
culture.”
To learn more about SPR and see currently available employment
opportunities, visit https://www.sprtherapeutics.com/careers
About the SPRINT PNS System The SPRINT® PNS
System, by SPR® Therapeutics, marks an innovative shift in the
treatment of pain. Our breakthrough, 60-day
treatment is a First-Line PNS™ option uniquely proposed
to recondition the central
nervous system to provide significant and sustained
relief from chronic pain — without a permanent implant,
nerve destruction or the risk of addiction. The system has been
studied extensively for low back pain, knee pain, shoulder pain,
post-amputation pain, and chronic and acute postoperative pain,
is cleared for use up to 60 days, and is recognized by leading
pain management centers. Market research indicates that this
breakthrough neuromodulation treatment is a patient-preferred
alternative to more invasive options.
The SPRINT PNS System is indicated for up to 60 days for:
Symptomatic relief of chronic, intractable pain, post-surgical and
post-traumatic acute pain; symptomatic relief of post-traumatic
pain; symptomatic relief of postoperative pain. The SPRINT PNS
System is not intended to be placed in the region innervated by the
cranial and facial nerves.
Physicians should use their best judgment when deciding when to
use the SPRINT PNS System. For more information see the SPRINT PNS
System IFU. Most common adverse events are skin irritation and
erythema. Results may vary. Rx only.
For additional information regarding safety and efficacy, visit:
SPR Safety Information.
About SPR Therapeutics, Inc.SPR Therapeutics is
a privately held medical device company, providing patients with a
non-opioid, minimally invasive pain treatment option. Our SPRINT®
PNS System fulfills a critical unmet need for a drug-free,
surgery-free option for millions who suffer from chronic pain.
Backed by the largest body of clinical evidence in peripheral nerve
stimulation for the treatment of pain, SPR has demonstrated
commercial demand in untapped peripheral (shoulder and knee) and
back pain markets and built an incredibly strong foundation for
commercial growth. Headquartered in Cleveland, OH with satellite
offices in Chapel Hill, NC and Minneapolis, MN, SPR’s Senior
Management team includes experienced industry veterans with nearly
200 years of collective pain market and MedTech expertise, all
driven by our purpose – to improve the quality of patients’ lives
by providing them with a minimally-invasive, drug-free,
surgery-free solution to manage their acute and chronic pain.
More information can be found at www.SPRTherapeutics.com.
SPR Contacts:
Michelle McDonald
Vice President – Marketing
mmcdonald@sprtherapeutics.com
844.378.9108
Dave Folkens
Public Relations
dfolkens@sprtherapeutics.com
612.978.6547